Hansa Biopharma AB (HNSA)

Currency in SEK
25.88
-0.34(-1.30%)
Closed·

HNSA Earnings

Latest Release
Jul 17, 2025
EPS / Forecast
-2.53 / -1.66
Revenue / Forecast
49.10M / 59.05M
EPS Revisions
Last 90 days
Release Date
Period End
EPS
/Forecast
Revenue
/Forecast
EPS Surprise %
Revenue Surprise %
Reaction
09/2025--/-1.56--/68.29M----Free Sign Up
06/2025-2.53/-1.6649.1M/59.05M-52.41%-16.85%Free Sign Up
03/2025-0.55/-2.6166.3M/51.24M+78.93%+29.39%Free Sign Up
12/2024-4.08/-1.9832.3M/70.59M-106.06%-54.24%Free Sign Up
09/2024-1.53/-2.4248.7M/54.21M+36.78%-10.16%Free Sign Up
06/2024-3.3/-2.7834.3M/54.27M-18.71%-36.8%Free Sign Up
03/2024-4.15/-4.1556M/56M0%0%Free Sign Up
12/2023-2.4/-2.450.4M/50.4M0%0%Free Sign Up
09/2023-4.78/-4.7822.8M/22.8M0%0%Free Sign Up
06/2023-4.79/-4.7936.7M/36.7M0%0%Free Sign Up

All numbers in SEK

Hansa Biopharma AB Earnings Call Summary for Q2/2025

  • Q2 2025 EPS of -2.53 missed forecast (-1.82); revenue of SEK 49.1M fell short of SEK 59.11M estimate
  • Ideferix sales up 76% YoY; gross margin improved to 66% from 35% in 2024
  • Restructuring completed, expecting SEK 60M annual savings; cash runway extended to early Q2 2026
  • Stock rose 3.93% post-earnings despite misses; company aims to exceed 2024's SEK 140M product sales in 2025
  • Preparing for key trial data in kidney transplantation and anti-GBM disease; German program pause may affect EU market
Last Updated: 17/07/2025, 14:00
Read Full Transcript

FAQ

What Is Hansa Biopharma's Earnings Per Share (TTM)?

The Hansa Biopharma EPS (TTM) is -8.72.

When Is The Next Hansa Biopharma Earnings Date?

Hansa Biopharma will release its next earnings report on 22 Oct 2025.

What Is Hansa Biopharma’s Revenue Forecasts For Upcoming Quarters?

Hansa Biopharma’s revenue forecast is 68.29M.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.